New Findings on Xenografts Described by Investigators at Yale University [Ovarian and Uterine Carcinosarcomas Are Sensitive In Vitro and In Vivo To Elimusertib, a Novel Ataxia-telangiectasia and Rad3-related (Atr) Kinase Inhibitor]

Press/Media

Period14 Feb 2023

Media coverage

1

Media coverage

  • TitleNew Findings on Xenografts Described by Investigators at Yale University [Ovarian and Uterine Carcinosarcomas Are Sensitive In Vitro and In Vivo To Elimusertib, a Novel Ataxia-telangiectasia and Rad3-related (Atr) Kinase Inhibitor]
    Media name/outletNewsRx Women's Health Daily
    Country/TerritoryUnited States
    Date14/02/23
    PersonsPeter Dottino, Yang Yang